About Us

 Ra Medical Systems was founded in 2002 to design, develop, and commercialize excimer lasers as tools for the treatment of vascular and dermatological diseases. The Company was incorporated in California on September 4, 2002 and reincorporated in Delaware in July 2018.

Pharos excimer laser system was launched in October 2004 and is used as a tool in the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma.

In May 2017, DABRA laser system and disposable DABRA catheter received FDA 510(k) clearance in the U.S. for the intended use of ablating a channel in occlusive peripheral vascular disease.

DABRA and Pharos are both based on our core excimer laser technology platform and deploy similar mechanisms of action. Independent in vivo and in vitro research studies have demonstrated that 308 nanometer excimer laser light, which is the same wavelength used in DABRA and Pharos, increases T-cell apoptosis, or cell death, which may produce an immunosuppressive effect.

We manufacture our DABRA and Pharos excimer lasers and catheters in our approximately 32,000-square-foot facility located in Carlsbad, California. Our vertically integrated facility is ISO 13485 certified and is licensed by the state of California to manufacture our sterile, single-use catheters in our controlled environments.